NOVOCURE LTD. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Directors: Ashley Cordova

NOVOCURE LTD.’s own tally for this item (“Elect Director: Ashley Cordova”): 82,362,437 for, 340,654 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Asaf Danziger

NOVOCURE LTD.’s own tally for this item (“Elect Director: Asaf Danziger”): 81,932,893 for, 745,479 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: William Doyle

NOVOCURE LTD.’s own tally for this item (“Elect Director: William Doyle”): 81,900,273 for, 800,682 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,189,759 for, 1,326 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Jeryl Hilleman

NOVOCURE LTD.’s own tally for this item (“Elect Director: Jeryl Hilleman”): 82,196,663 for, 494,915 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: David Hung

NOVOCURE LTD.’s own tally for this item (“Elect Director: David Hung”): 82,142,624 for, 531,558 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Kinyip Gabriel Leung

NOVOCURE LTD.’s own tally for this item (“Elect Director: Kinyip Gabriel Leung”): 81,198,024 for, 1,499,970 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,153,054 for, 38,031 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Martin Madden

NOVOCURE LTD.’s own tally for this item (“Elect Director: Martin Madden”): 82,199,569 for, 497,393 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Allyson Ocean

NOVOCURE LTD.’s own tally for this item (“Elect Director: Allyson Ocean”): 82,147,906 for, 527,676 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Timothy Scannell

NOVOCURE LTD.’s own tally for this item (“Elect Director: Timothy Scannell”): 82,199,320 for, 495,578 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Kristin Stafford

NOVOCURE LTD.’s own tally for this item (“Elect Director: Kristin Stafford”): 82,206,597 for, 490,733 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,191,085 for, 0 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: William Vernon

NOVOCURE LTD.’s own tally for this item (“Elect Director: William Vernon”): 81,646,756 for, 1,048,764 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,118,518 for, 72,567 against, 16,878 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: The approval of our 2025 Employee Share Purchase Plan.

NOVOCURE LTD.’s own tally for this item (“4. Approval of the Company's 2025 Employee Share Purchase Plan”): 82,005,031 for, 684,858 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the Company's 2025 Employee Share Purchase Plan was approved as an ordinary resolution based upon the following votes:”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 46,164,419 for, 43,768 against, 0 abstained.

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

Description as filed by funds: A non-binding advisory vote to approve executive compensation.

NOVOCURE LTD.’s own tally for this item (“3. Approval of a non-binding advisory vote to approve executive compensation”): 80,626,467 for, 2,042,002 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve executive compensation on a non-binding advisory basis was approved as an ordinary resolution based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of NOVOCURE LTD.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (7 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 60 managers: 45,965,218 for, 198,977 against, 16,878 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 225 managers: 60,047,407 for, 1,704,576 against, 1,290 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2025.

NOVOCURE LTD.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 91,489,770 for, 1,216,673 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve and ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, …”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 46,118,060 for, 46,135 against, 16,958 abstained.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.